Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2015 1
2016 3
2017 2
2018 1
2019 1
2020 3
2021 2
2022 1
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Refractory Malignant Skin Neoplasm"
Page 1
PD-1 Antibody Monotherapy for Malignant Melanoma: A Systematic Review and Meta-Analysis.
Lin Z, Chen X, Li Z, Luo Y, Fang Z, Xu B, Han M. Lin Z, et al. PLoS One. 2016 Aug 2;11(8):e0160485. doi: 10.1371/journal.pone.0160485. eCollection 2016. PLoS One. 2016. PMID: 27483468 Free PMC article. Review.
Five trials involving 2,828 adult patients were included in this meta-analysis. In patients with previously untreated or refractory melanoma, treatment with PD-1 antibodies significantly improved the six-month progression-free survival (PFS) (HR 0.55, 95% CI 0.50-0.60, P&l …
Five trials involving 2,828 adult patients were included in this meta-analysis. In patients with previously untreated or refractory m …
Laser treatment of infantile hemangioma: A systematic review.
Chinnadurai S, Sathe NA, Surawicz T. Chinnadurai S, et al. Lasers Surg Med. 2016 Mar;48(3):221-33. doi: 10.1002/lsm.22455. Epub 2015 Dec 29. Lasers Surg Med. 2016. PMID: 26711436 Review.
In the era of beta-blocker therapy, laser treatment may retain an important role in the treatment of residual and refractory lesions....
In the era of beta-blocker therapy, laser treatment may retain an important role in the treatment of residual and refractory lesions. …
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
Forbes C, Shirran L, Bagnall AM, Duffy S, ter Riet G. Forbes C, et al. Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280. Health Technol Assess. 2001. PMID: 11701100 Free article. Review.
Current recommendations suggest that first-line chemotherapy for ovarian cancer should involve paclitaxel and platinum (Pt)-based therapy (cisplatin/ carboplatin), however, most patients develop resistant or refractory disease and require second-line therapy. Patients may …
Current recommendations suggest that first-line chemotherapy for ovarian cancer should involve paclitaxel and platinum (Pt)-based therapy (c …
Systematic review and meta-analysis efficacy and safety of immune checkpoint inhibitors in advanced melanoma patients with anti-PD-1 progression: a systematic review and meta-analysis.
Alrabadi NN, Abushukair HM, Ababneh OE, Syaj SS, Al-Horani SS, Qarqash AA, Darabseh OA, Al-Sous MM, Al-Aomar SR, Ahmed YB, Haddad R, Al Qarqaz FA. Alrabadi NN, et al. Clin Transl Oncol. 2021 Sep;23(9):1885-1904. doi: 10.1007/s12094-021-02598-6. Epub 2021 Apr 20. Clin Transl Oncol. 2021. PMID: 33877531
Here, we evaluate the efficacy and safety of different melanoma FDA-approved ICI modalities used in post-anti-PD-1 refractory settings. MATERIALS AND METHODS: We searched the PubMed database and the ASCO meetings library for studies on advanced melanoma patients with cance …
Here, we evaluate the efficacy and safety of different melanoma FDA-approved ICI modalities used in post-anti-PD-1 refractory setting …
The clinical and humanistic burden of cutaneous T-cell lymphomas and response to conventional and novel therapies: results of a systematic review.
Dalal M, Mitchell S, McCloskey C, Zagadailov E, Gautam A. Dalal M, et al. Expert Rev Hematol. 2020 Apr;13(4):405-419. doi: 10.1080/17474086.2020.1717945. Epub 2020 Jan 31. Expert Rev Hematol. 2020. PMID: 31958235
Skin problems pose considerable symptom burden, while advanced disease stage is associated with poorer QoL. ...Overall response rate (ORR) ranged from 14% (belinostat) to 95% (total skin electron beam therapy). ORRs >50% were reported for several therapies includ …
Skin problems pose considerable symptom burden, while advanced disease stage is associated with poorer QoL. ...Overall response rate …
Association of Bullous Pemphigoid With Immune Checkpoint Inhibitor Therapy in Patients With Cancer: A Systematic Review.
Asdourian MS, Shah N, Jacoby TV, Reynolds KL, Chen ST. Asdourian MS, et al. JAMA Dermatol. 2022 Aug 1;158(8):933-941. doi: 10.1001/jamadermatol.2022.1624. JAMA Dermatol. 2022. PMID: 35612829
Immune checkpoint inhibitor-induced bullous pemphigoid often occurred during the course of anti-PD-1, PD-L1, or cytotoxic T lymphocyte-associated antigen 4 therapy but was also found to develop up to several months after treatment cessation. Prodromal symptoms, such as pruritus o …
Immune checkpoint inhibitor-induced bullous pemphigoid often occurred during the course of anti-PD-1, PD-L1, or cytotoxic T lymphocyte-assoc …
Relative Efficacy of Nonoperative Treatment of Keratoacanthomas.
Seger EW, Tarantino IS, Neill BC, Wang T. Seger EW, et al. J Cutan Med Surg. 2020 Jan/Feb;24(1):41-46. doi: 10.1177/1203475419882336. Epub 2019 Oct 8. J Cutan Med Surg. 2020. PMID: 31591899
BACKGROUND: Keratoacanthomas (KAs) are neoplasms of squamous epithelium which exhibit rapid growth and are often difficult to distinguish clinically from squamous cell carcinoma. Excision is the most common treatment, but in refractory cases or for KAs in cosmetical …
BACKGROUND: Keratoacanthomas (KAs) are neoplasms of squamous epithelium which exhibit rapid growth and are often difficult to disting …
Photodynamic therapy as an alternative treatment for relapsed or refractory mycosis fungoides: A systemic review.
Xue J, Liu C, Liu Y. Xue J, et al. Photodiagnosis Photodyn Ther. 2017 Mar;17:87-91. doi: 10.1016/j.pdpdt.2016.11.010. Epub 2016 Nov 23. Photodiagnosis Photodyn Ther. 2017. PMID: 27888162 Review.
Therapies such as localized chemotherapy, photochemotherapy and radiotherapy are often employed when lesions of refractory or relapsing mycosis fungoides are resistant to conventional therapies. ...In this article, we systematically reviewed and discussed clinical applicat …
Therapies such as localized chemotherapy, photochemotherapy and radiotherapy are often employed when lesions of refractory or relapsi …
How different is invasive fusariosis in pediatric patients than in adults? A systematic review.
Rossato L, Carlesse F, Nobrega de Almeida J Jr, Kontoyiannis DP, Colombo AL. Rossato L, et al. Curr Opin Infect Dis. 2021 Dec 1;34(6):619-626. doi: 10.1097/QCO.0000000000000776. Curr Opin Infect Dis. 2021. PMID: 34751181
RECENT FINDINGS: One hundred and six cases were retrieved, and hematologic malignancy was reported in 64% (68/106) of the cases. The most frequent anatomic sites involved were skin 66% (70/106), blood 47% (50/106), and lungs 35% (37/106), bone and joint (8%, 09/106), and e …
RECENT FINDINGS: One hundred and six cases were retrieved, and hematologic malignancy was reported in 64% (68/106) of the cases. The most fr …
15 results